SCM
Silverarc Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-250,551
| Closed | -$1.64M | – | 82 |
|
|
2024
Q1 | $1.64M | Sell |
250,551
-266,448
| -52% | -$1.75M | 0.46% | 52 |
|
|
2023
Q4 | $3.36M | Buy |
516,999
+16,999
| +3% | +$110K | 1% | 36 |
|
|
2023
Q3 | $2.52M | Sell |
500,000
-99,668
| -17% | -$501K | 0.76% | 34 |
|
|
2023
Q2 | $5.25M | Sell |
599,668
-68,254
| -10% | -$597K | 1.62% | 18 |
|
|
2023
Q1 | $7.91M | Sell |
667,922
-32,078
| -5% | -$380K | 3.26% | 6 |
|
|
2022
Q4 | $7.13M | Buy |
700,000
+685,527
| +4,737% | +$6.98M | 2.04% | 13 |
|
|
2022
Q3 | $85K | Buy |
+14,473
| New | +$85K | 0.03% | 67 |
|